Ensign Peak Advisors »

Odyssey Therapeutics shares owned by Ensign Peak Advisors

Quarter-by-quarter ownership of Odyssey Therapeutics shares owned by Ensign Peak Advisors from 13F filings

Historical chart of Ensign Peak Advisors investment in Odyssey Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Odyssey Therapeutics held by Ensign Peak Advisors consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Odyssey Therapeutics by Ensign Peak Advisors

Quarter filed Position value Share count Share price at filing
2026-06-30 $1.2M 65k 18.71

More positions owned by Ensign Peak Advisors

NVIDIA Corporation (NVDA)
Apple (AAPL)
Microsoft Corporation (MSFT)
Alphabet Cap Stk Cl A (GOOGL)
Amazon (AMZN)
Broadcom (AVGO)
Alphabet Cap Stk Cl C (GOOG)
Meta Platforms Cl A (META)
Micron Technology (MU)
Eli Lilly & Co. (LLY)
JPMorgan Chase & Co. (JPM)
Mastercard Incorporated Cl A (MA)
Tesla Motors (TSLA)
Advanced Micro Devices (AMD)
Applied Materials (AMAT)

View all positions for Ensign Peak Advisors

Top funds holding Odyssey Therapeutics

FMR
Sr One Capital Management
Tpg Gp A
Lightspeed Management Company
OrbiMed Advisors
Sanofi
Deerfield Management Company
Sands Capital Ventures
Hillhouse Capital Advisors
General Catalyst Group Management
Affinity Asset Advisors
Adage Capital Partners GP
Vanguard Capital Management
Foresite Capital Management V
Vivo Capital

View all funds holding Odyssey Therapeutics